HY-100128-25mg
|
MedChemexpress LLC
|
DM1-SMe [CAS 138148-68-2]
|
|
Cancer-programmed cell death
|
|
HY-100128-5mg
|
MedChemexpress LLC
|
DM1-SMe [CAS 138148-68-2]
|
|
Cancer-programmed cell death
|
|
HY-100128-50mg
|
MedChemexpress LLC
|
DM1-SMe [CAS 138148-68-2]
|
|
Cancer-programmed cell death
|
|
HY-100195-10mg
|
MedChemexpress LLC
|
SAR-020106 [CAS 1184843-57-9]
|
|
Cancer-Kinase/protease
|
|
HY-100195-25mg
|
MedChemexpress LLC
|
SAR-020106 [CAS 1184843-57-9]
|
|
Cancer-Kinase/protease
|
|
HY-100195-5mg
|
MedChemexpress LLC
|
SAR-020106 [CAS 1184843-57-9]
|
|
Cancer-Kinase/protease
|
|
HY-100195-50mg
|
MedChemexpress LLC
|
SAR-020106 [CAS 1184843-57-9]
|
|
Cancer-Kinase/protease
|
|
HY-100201-10mg
|
MedChemexpress LLC
|
A-196 [CAS 1982372-88-2]
|
|
Cancer-programmed cell death
|
|
HY-100201-100mg
|
MedChemexpress LLC
|
A-196 [CAS 1982372-88-2]
|
|
Cancer-programmed cell death
|
|
HY-100201-5mg
|
MedChemexpress LLC
|
A-196 [CAS 1982372-88-2]
|
|
Cancer-programmed cell death
|
|
HY-100201-50mg
|
MedChemexpress LLC
|
A-196 [CAS 1982372-88-2]
|
|
Cancer-programmed cell death
|
|
HY-100223-10mg
|
MedChemexpress LLC
|
Calpeptin [CAS 117591-20-5]
|
|
COVID-19-immunoregulation
|
|
HY-100223-100mg
|
MedChemexpress LLC
|
Calpeptin [CAS 117591-20-5]
|
|
COVID-19-immunoregulation
|
|
HY-100223-25mg
|
MedChemexpress LLC
|
Calpeptin [CAS 117591-20-5]
|
|
COVID-19-immunoregulation
|
|
HY-100223-5mg
|
MedChemexpress LLC
|
Calpeptin [CAS 117591-20-5]
|
|
COVID-19-immunoregulation
|
|
HY-100223-50mg
|
MedChemexpress LLC
|
Calpeptin [CAS 117591-20-5]
|
|
COVID-19-immunoregulation
|
|
HY-100269-1mg
|
MedChemexpress LLC
|
Chymase-IN-1 [CAS 862090-74-2]
|
|
COVID-19-immunoregulation
|
|
HY-10029-10mg
|
MedChemexpress LLC
|
Nutlin-3a [CAS 675576-98-4]
|
|
Cancer-programmed cell death
|
|
HY-10029-100mg
|
MedChemexpress LLC
|
Nutlin-3a [CAS 675576-98-4]
|
|
Cancer-programmed cell death
|
|
HY-10029-25mg
|
MedChemexpress LLC
|
Nutlin-3a [CAS 675576-98-4]
|
|
Cancer-programmed cell death
|
|
HY-10029-5mg
|
MedChemexpress LLC
|
Nutlin-3a [CAS 675576-98-4]
|
|
Cancer-programmed cell death
|
|
HY-10029-50mg
|
MedChemexpress LLC
|
Nutlin-3a [CAS 675576-98-4]
|
|
Cancer-programmed cell death
|
|
HY-10037-10mg
|
MedChemexpress LLC
|
Quiflapon [CAS 136668-42-3]
|
|
COVID-19-immunoregulation
|
|
HY-10037-100mg
|
MedChemexpress LLC
|
Quiflapon [CAS 136668-42-3]
|
|
COVID-19-immunoregulation
|
|
HY-10037-5mg
|
MedChemexpress LLC
|
Quiflapon [CAS 136668-42-3]
|
|
COVID-19-immunoregulation
|
|